A hormone, called betatrophin, that may significantly improve type 2 diabetes treatment has been discovered by scientists at the Harvard Stem Cell Institute (HSCI), according to a report published in Cell.
SOGA, a protein that lowers blood glucose, is missing in type 1 patients. SOGA is released when insulin is released and works by blocking the production of glycogen when food is being consumed.
At TEDxSydney 2013 the Professor of Genetics at Harvard Medical School shares a new concept about why we age and how it should be possible to develop medicines to reverse it.
The Food and Drug Administration will hold a meeting in June to reassess the safety of GlaxoSmithKline’s former blockbuster diabetes drug Avandia.
Different types and doses of statins seem to correlate with distinct risks of developing new-onset diabetes mellitus (DM).
What if someone said that you — someone with type 1 diabetes — could take a pill and your insulin requirements would not only drop, but they might be eliminated completely?
There are several classes of drugs that are used to lower blood sugar, improve your body’s response to insulin or cause weight loss so your body can improve its ability to regulate insulin and sugar
A new treatment option will soon be available to people with type 2 diabetes with the FDA’s approval on Friday of Invokana, a first-in-class medication to lower blood sugar.
Yet while adding new items to the expanding type 2 diabetes drugs arsenal has its positive side, it’s not good enough, and here’s why.
University of Montreal researchers have discovered a novel molecular mechanism that can potentially slows the aging process and may prevent the progression of some cancers.
Novo Nordisk, in conjunction with Danish manufacturer Merrion Pharmaceuticals Plc., have tested oral insulin and successfully completed early stages trials.
The Food and Drug Administration says it has approved a first-of-a-kind diabetes drug from Johnson & Johnson that uses a new method to lower blood sugar.
Novo Nordisk’s oral insulin successfully completed an early-stage study bringing what would be the first product of its kind a step closer to market.
The current recommendation from both the Food and Drug Administration and the FDA and Health Canada, is that the benefits outweigh the risk for people who need to take statins.
Adhering to your diabetes medication schedule will mean fewer blood sugar ups and downs, but that’s often easier said than done. These ideas will help you stay on the clock.
The U.S. Food and Drug Administration is looking into new evidence that suggests a group of recently approved diabetes drugs can increase the risk of pancreatitis and other problems.
Recently, scientists reviewed 10 studies that evaluated the use of medication alone or in combination with other antidiabetic drugs. Based on their review, investigators found alogliptin to be an effective therapy to control blood sugar levels.
The drug Ranexa (ranolazine) may help reduce chest pain in people with type 2 diabetes, a new study finds.
A class of medications commonly prescribed to lower blood sugar in diabetic patients appears to protect them from developing heart failure.
Drugs that combat aging may be available within five years, following landmark work led by an Australian researcher.